|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date20 Jun 2023 |
100 Clinical Results associated with argenx Japan KK
0 Patents (Medical) associated with argenx Japan KK
100 Deals associated with argenx Japan KK
100 Translational Medicine associated with argenx Japan KK